Gene | Effect a | Beta | 95% CI | P | |
---|---|---|---|---|---|
Lower | Upper | ||||
AHRR | ACME | 4.5 × 10− 4 | 1.6 × 10− 4 | 8.3 × 10− 4 | < 1.0 × 10− 4 |
ADE | 2.9 × 10− 3 | 1.7 × 10− 3 | 4.1 × 10− 3 | < 1.0 × 10− 4 | |
Total Effect | 3.3 × 10− 3 | 2.1 × 10− 3 | 4.5 × 10− 3 | < 1.0 × 10− 4 | |
Prop | 13.4% | 4.6% | 25.6% | 2.0 × 10− 4 | |
CAPN8 | ACME | 3.4 × 10− 4 | 8.2 × 10− 5 | 6.8 × 10− 4 | < 1.0 × 10− 4 |
ADE | 3.0 × 10− 3 | 1.8 × 10− 3 | 4.2 × 10− 3 | < 1.0 × 10− 4 | |
Total Effect | 3.3 × 10− 3 | 2.1 × 10− 3 | 4.5 × 10− 3 | < 1.0 × 10− 4 | |
Prop | 9.8% | 2.4% | 21.7% | 2.2 × 10− 3 | |
GPR15 | ACME | 7.7 × 10− 4 | 3.9 × 10− 4 | 1.2 × 10− 3 | < 1.0 × 10− 4 |
ADE | 2.6 × 10− 3 | 1.4 × 10− 3 | 3.7 × 10− 3 | < 1.0 × 10− 4 | |
Total Effect | 3.4 × 10− 3 | 2.2 × 10− 3 | 4.4 × 10− 3 | < 1.0 × 10− 4 | |
Prop | 22.8% | 11.3% | 39.4% | < 1.0 × 10− 4 | |
HDGF | ACME | 4.2 × 10− 4 | 1.6 × 10− 4 | 7.6 × 10− 4 | < 1.0 × 10− 4 |
ADE | 2.9 × 10− 3 | 1.8 × 10− 3 | 4.1 × 10− 3 | < 1.0 × 10− 4 | |
Total Effect | 3.4 × 10− 3 | 2.2 × 10− 3 | 4.5 × 10− 3 | < 1.0 × 10− 4 | |
Prop | 12.3% | 4.7% | 24.6% | 8.0 × 10− 4 | |
RPS6KA1 | ACME | 3.0 × 10− 4 | 1.8 × 10− 5 | 6.7 × 10− 4 | 0.040 |
ADE | 3.0 × 10− 3 | 1.9 × 10− 3 | 4.2 × 10− 3 | < 1.0 × 10− 4 | |
Total Effect | 3.3 × 10− 3 | 2.1 × 10− 3 | 4.5 × 10− 3 | < 1.0 × 10− 4 | |
Prop | 8.6% | 5% | 20.6% | 0.032 |